Mechanisms of kinin B1-receptor-induced hypotension in the anesthetized dog

Journal of Cardiovascular Pharmacology

Volumn 28, Issue 5, 1996, Pages 645-650

  Lamontagne, Daniel ^a   Nakhostine, Nabil ^a   Couture, Réjean ^a   Nadeau, Réginald ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Bradykinin; Cardiovascular reflex; des Arg9 bradykinin; Dog; Nitric oxide; Vasodilation

Indexed keywords

BRADYKININ; BRADYKININ B1 RECEPTOR; BRADYKININ B1 RECEPTOR AGONIST; BRADYKININ B2 RECEPTOR; BRADYKININ[1-8]; NITRIC OXIDE; BRADYKININ RECEPTOR; BRADYKININ, DES ARG(9); BRADYKININ, DES-ARG(9)-; DRUG DERIVATIVE; ENZYME INHIBITOR; N(G) NITROARGININE;

ADOLESCENT; ARTICLE; CARDIOVASCULAR REFLEX; CHRONOTROPISM; DOG; DRUG MECHANISM; FEMALE; HEMODYNAMICS; HYPOTENSION; INOTROPISM; INTRAARTERIAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; VASODILATATION; ANIMAL; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG EFFECT; DRUG POTENTIATION; PATHOPHYSIOLOGY; PHYSIOLOGY; VAGOTOMY;

ANIMALS; BRADYKININ; DOGS; ENZYME INHIBITORS; FEMALE; HEMODYNAMIC PROCESSES; HYPOTENSION; MALE; NITRIC OXIDE; NITROARGININE; RECEPTOR, BRADYKININ B1; RECEPTORS, BRADYKININ; VAGOTOMY;

EID: 0029658743     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199611000-00006     Document Type: Article

References (24)

1. O'Shaughnessy KM, Newman CM, Warren JB. Inhibition in the rat of nitric oxide synthesis in vivo does not attenuate the hypotensive action of acetylcholine, ATP or bradykinin. Exp Physiol 1992;77:285-92.
2. 2 receptors of vasodepressor responses to intravenously administered kinins in anaesthetized dogs. Br J Pharmacol 1993;110:71-6.
3. 2-induced vasodilatation in dogs. Am J Physiol 1994;266:H99-106.
4. Regoli D, Barabé J. Pharmacology of bradykinin and related kinins. Pharmacol Rev 1980;32:1-46.
5. Lamontagne D, König A, Bassenge E, Busse R. Prostacyclin and nitric oxide contribute to the vasodilator action of acetylcholine and bradykinin in the intact rabbit coronary bed. J Cardiovasc Pharmacol 1992;20:652-7.
6. Holzmann S, Kukovetz WR, Windischhofer W, Paschke E, Graier WF. Pharmacologic differentiation between endothelium-dependent relaxations sensitive and resistant to nitro-L-arginine in coronary arteries. J Cardiovasc Pharmacol 1994;23:747-56.
7. 9-bradykinin in vitro and in vivo. Br J Pharmacol 1987;92:257-64.
8. 1 receptor-mediated relaxation in the isolated rabbit carotid artery. Eur J Pharmacol 1993;239:63-7.
9. 1 receptors in vivo during antigen arthritis. Agents Actions 1991;34:191-3.
10. 9-BK: influence of enalaprilat. Am J Physiol (in press).
11. Baydoun AR, Woodward B. Effects of bradykinin in the rat isolated perfused heart - role of kinin receptors and endothelium-derived relaxing factor. Br J Pharmacol 1991;103:1829-33.
12. Rhaleb N-E, Dion S, Barabé J, et al. Receptors for kinins in isolated arterial vessels of dogs. Eur J Pharmacol 1989;162:419-27.
13. 2-kinin receptors in the renal tubular and hemodynamic response to bradykinin. Am J Physiol 1992;262:R72-6.
14. G-nitro-L-arginine (N5-[imino(nitroamino)methyl]-L-ornithine) impairs endothelium-dependent dilations by inhibiting cytosolic nitric oxide synthesis from L-arginine. Naunyn Schmiedebergs Arch Pharmacol 1990;341:143-7.
15. G-Nitro-L-arginine antagonizes endothelium-dependent dilator responses by inhibiting endothe- lium-derived relaxing factor release in the isolated rabbit heart. Pflugers Arch 1991;418:266-70.
16. G-amino-L-arginine on EDRF function in the rat: evidence for continuous basal EDRF release. J Pharmacol Exp Ther 1991;257:1208-15.
17. G-nitro-L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ Res 1993;72:387-95.
18. Moncada S, Higgs A. Mechanisms of disease: the L-arginine-nitric oxide pathway. N Engl J Med 1993;329:2002-12.
19. Richard V, Tanner FC, Tschudi M, Lüscher TF. Different activation of L-arginine pathway by bradykinin, serotonin, and clonidine in coronary arteries. Am J Physiol 1990;259:H1433-9.
20. Tschudi M, Richard V, Bühler FR, Lüscher TF. Importance of endothelium-derived nitric oxide in porcine coronary resistance arteries. Am J Physiol 1990;260:H13-20.
21. Huckstorf C, Zanzinger J, Fink B, Bassenge E. Reduced nitric oxide formation causes coronary vasoconstriction and impaired dilator responses to endogenous agonists and hypoxia in dogs. Naunyn Schmiedebergs Arch Pharmacol 1994;349:367-73.
22. Nagao T, Vanhoutte PM. Hyperpolarization as a mechanism for endothelium-dependent relaxations in the porcine coronary artery. J Physiol (Lond) 1992;445:355-67.
23. Nagao T, Vanhoutte PM. Characterization of endothelium-dependent relaxations resistant to nitro-L-arginine in the porcine coronary artery. Br J Pharmacol 1992;107:1102-7.
24. Félétou M, Vanhoutte PM. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br J Pharmacol 1988;93:515-24.